Assets, income, and the risk of people aged 80 and over in Germany developing dementia: what are the connections? Do economic inequalities play a role? Researchers from Germany, Great Britain, and Australia investigated these questions. To get straight to the point: there is a connection between wealth and dementia. „This knowledge has the potential to advance research..."
At the 35th Alzheimer Europe Conference in Bologna, Italy, digiDEM Bayern presented its latest research findings through lectures and poster presentations. The overarching theme of this year's international conference for dementia research was „Connecting science and communities: The future of dementia care.“ The conference, held from October 6th to 10th, 2025, at the Bologna Congress Center...
digiDEM Bayern schreibt eine Erfolgsgeschichte fort: Mit mehr als 3.000 Teilnehmenden hat das größte Demenzregister Deutschlands einen neuen Höchststand erreicht. Das vom Bayerischen Staatsministerium für Gesundheit, Pflege und Prävention (StMGP) geförderte Leuchtturmprojekt zählt damit zugleich zu den größten europäischen Vorhaben zur Erfassung von Langzeitdaten im Bereich der Versorgungsforschung zu Demenzen. …
Anlässlich des 24. Deutschen Kongresses für Versorgungsforschung (DKVF) in Hamburg hat digiDEM Bayern zu seinem wissenschaftlichen Symposium eingeladen. Auf dem Campus des Universitätsklinikums Eppendorf (UKE), wo der DKVF vom 22. bis 24. September 2024 stattfand, präsentierten die digiDEM Bayern-Forschenden aktuelle Forschungsergebnisse. An der Veranstaltung des Deutschen Netzwerks Versorgungsforschung (DNVF) nahmen mehr als 1.100 Versorgungsforschende, …
Whether for smartphones, tablets, or as a web-based application on a PC: For over four years, doctors have been able to prescribe so-called digital health applications (DiGA). However, since their introduction, DiGAs, which are intended to improve healthcare, have often been the cause of conflicts between the stakeholders involved, such as...
Blood biomarker tests and cognitive screenings: How are these tests for early dementia detection actually perceived by the public? What experiences have older people had with them? In a US study published in January 2025, researchers uncovered interesting findings. How familiar are US citizens aged 65 to 80 with...
The MAKS® therapy was honored with an MSD Health Award 2024. The MAKS® program, consisting of several components, has been proven to help people with mild to moderate dementia maintain their cognitive abilities for as long as possible. The non-pharmacological activation therapy helps to slow the progression of dementia and alleviate its symptoms. For the award...
